Atea Pharmaceuticals, Inc. (AVIR) stock
AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.99+0.03 (+0.76%)
Close on Nov 18, 2026Market cap $320.02MP/E –Yield –
Atea Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Atea Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2021 was 34.5%. For fiscal 2021 it was 34.5%, against -22.5% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 34.5% | +57.0 |
| FY2020 | Dec 31, 2020 | -22.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | 60.9% | – |
| Q3 FY2021 | Sep 30, 2021 | -85.9% | – |
| Q2 FY2021 | Jun 30, 2021 | 2.5% | – |
| Q1 FY2021 | Mar 31, 2021 | 46.5% | – |
See a number that looks wrong?